Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Snail family transcriptional repressor 3 (SNAI3) is a zinc finger transcription factor and member of the Snail protein family, which includes SNAI1 and SNAI2. SNAI3 functions as a transcriptional repressor by binding to canonical E-box DNA sequences (CAGGTG and CACCTG), thereby inhibiting the transactivation of target genes, particularly those involved in muscle cell differentiation. Highest expression levels are observed in thymus and skeletal muscle. Unlike SNAI1 and SNAI2, which have well-defined roles in epithelial-mesenchymal transition and tumor progression, SNAI3's physiological role in mammals remains less well characterized, and knockout studies in mice indicate it is not essential for embryogenesis[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Snail family transcriptional repressor 3 (SNAI3).